Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regulators split on gene therapy as patient shows signs of cancer.

× No keyword cloud information.

12 in total

1. 20 years of gene therapy for SCID.

Authors: Alain Fischer; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo
Journal: Nat Immunol Date: 2010-06 Impact factor: 25.606

2. Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.

Authors: Jiali Li; Sonya Lad; Guang Yang; Yunping Luo; Milena Iacobelli-Martinez; F James Primus; Ralph A Reisfeld; Erguang Li
Journal: J Virol Date: 2006-10-04 Impact factor: 5.103

3. Dendrimeric alkylated polyethylenimine nano-carriers with acid-cleavable outer cationic shells mediate improved transfection efficiency without increasing toxicity.

Authors: Terry W J Steele; Wayne Thomas Shier
Journal: Pharm Res Date: 2010-02-17 Impact factor: 4.200

4. Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors: Sara Pérez-Luz; Javier Díaz-Nido
Journal: J Biomed Biotechnol Date: 2010-08-24

5. Gene therapy for GM1 gangliosidosis: challenges of translational medicine.

Authors: Carl Hayward; Hitesh C Patel; Sanjay G Manohar; Alexander R Lyon
Journal: Ann Transl Med Date: 2015-05

Review 6. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.

Authors: Marta Carvalho; Bruno Sepodes; Ana Paula Martins
Journal: Front Med (Lausanne) Date: 2017-10-26

Regulators split on gene therapy as patient shows signs of cancer.

1. 20 years of gene therapy for SCID.

2. Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.

3. Dendrimeric alkylated polyethylenimine nano-carriers with acid-cleavable outer cationic shells mediate improved transfection efficiency without increasing toxicity.

4. Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

5. Gene therapy for GM1 gangliosidosis: challenges of translational medicine.

Review 6. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.

7. Functional characteristics of a highly specific integrase encoded by an LTR-retrotransposon.

8. Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice.

9. Para amino benzoic acid-derived self-assembled biocompatible nanoparticles for efficient delivery of siRNA.

Review 10. Recent Advances in CRISPR/Cas9 Delivery Strategies.